Csl Ltd Unsp ADR (CMXHY) 32.3900 $CMXHY Is This

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Csl Ltd Unsp ADR (CMXHY) 32.3900 $CMXHY

Is This Overlooked Stock Primed for More Growth?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Tue Mar 25, 1:30PM CDT
Blood products really don't get that much attention in the health care space, but it's a market worth more than $10 billion a year excluding hemophilia products and growing around 6% to 8% a year as indications and patient identification expand. ...

CNSI Selected by Two Maryland State Agencies for Separate IT Development and Support Contracts
PR Newswire - Tue Jan 21, 10:00AM CST
CNSI today announced it has been selected by the Maryland State Highway Authority (SHA) to provide Application Portfolio Business Services. As part of the task order under the State of Maryland - Consulting and Technical Services (CATS+) Master Contract, CNSI will continue to provide SHA's business applications development and maintenance for the next five years. CNSI also has been selected by the Maryland Port Administration (MPA) to continue providing programming and database management support services for an additional five years.

New Health Benefits Found in ReishiSmooth(TM) Coffee
PR Newswire - Tue Jan 21, 9:47AM CST
MycoTechnology Inc. announced today that their all-natural ReishiSmooth(TM) process delivers a healthier cup of coffee. The health benefits are derived from the beta-glucans found in the coffee, which have been shown to activate the human immune system.

iCo Therapeutics Begins Trading on the OTCQX Marketplace
PR Newswire - Fri Dec 20, 6:00AM CST
iCo Therapeutics (TSXV: ICO) (OTCQX: ICOTF), announced that its common shares will begin trading today on OTCQX International, a segment of the OTCQX marketplace in the U.S., under the symbol "ICOTF." iCo's common shares will also continue to trade on the TSX Venture Exchange under the symbol "ICO".

CMS Approves New Technology Add-On Payment for CSL Behring's Kcentra(TM)
PR Newswire - Tue Aug 13, 9:37AM CDT
CSL Behring today announced that the Centers for Medicare and Medicaid Services (CMS) has approved a new technology add-on payment (NTAP) for Kcentra(TM) (Prothrombin Complex Concentrate [Human]) for use in the inpatient hospital setting for the urgent reversal of warfarin therapy in adult patients with acute major bleeding. Kcentra, the first non-activated 4-factor prothrombin complex concentrate (4F-PCC), was approved by the U.S. Food and Drug Administration (FDA) in April 2013 for this use.

CSL Behring Presents Population Pharmacokinetic Model for Novel Recombinant Factor IX Hemophilia B Treatment That Supports Less Frequent Administration
PR Newswire - Wed Jul 03, 10:00AM CDT
CSL Behring today presented a population pharmacokinetic model for recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) at the International Society on Thrombosis and Haemostasis (ISTH) congress in Amsterdam. The model confirms earlier results from the first-in-human dose escalation trial, which demonstrated improved pharmacokinetics of rIX-FP, with prolonged half-life compared to currently available factor IX.

CSL Behring Presents Phase I Results From Study of Recombinant Fusion Protein Linking Coagulation Factor VIIa with Albumin (rVIIa-FP) in Healthy Volunteers
PR Newswire - Wed Jul 03, 10:00AM CDT
CSL Behring today presented Phase I data of their recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) in healthy volunteers at the International Society on Thrombosis and Haemostasis (ISTH) congress in Amsterdam.

CSL Behring International Trial Shows Clinical Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) for Once Weekly Prophylaxis in Patients with Severe Hemophilia B
PR Newswire - Wed Jul 03, 7:45AM CDT
Data presented by CSL Behring today showed clinical efficacy of a once-weekly dosing regimen of recombinant fusion protein linking coagulation Factor IX with albumin (rIX-FP). Results of the study were presented during an oral session at the International Society on Thrombosis and Haemostasis (ISTH) congress in Amsterdam.

CSL Behring Announces Results from Study of Recombinant Single-Chain Factor VIII (rVIII-SingleChain) for Treatment of Hemophilia A
PR Newswire - Tue Jul 02, 10:00AM CDT
CSL Behring today announced that pharmacokinetic results for its novel investigational recombinant coagulation single-chain factor VIII (rVIII-SingleChain) showed improved half-life over octocog alfa (the comparator). It also demonstrated a safety and efficacy profile that supports advancement to late-stage clinical development. The data were presented at the International Society on Thrombosis and Haemostasis (ISTH) congress in Amsterdam.

CSL Behring to Premiere Data from Broad Recombinant Clinical Development Program in Hemophilia at the International Society of Thrombosis and Haemostasis (ISTH) Congress
PR Newswire - Thu Jun 27, 8:00AM CDT
CSL Behring today announced it will present study data from three ongoing clinical trial programs evaluating the Company's novel recombinant factor VIIa (rVIIa-FP), VIII (rVIII-SingleChain) and IX (rIX-FP) agents for people with hemophilia A and B with and without inhibitors. The data will be presented at the International Society on Thrombosis and Haemostasis (ISTH) congress in Amsterdam. CSL Behring is the only company pursuing longer-acting rVIIa-FP and rIX-FP candidates based on recombinant albumin, and a rVIII-SingleChain compound that has been shown to improve the stability and half-life of factor VIII (FVIII).

CSL Behring Doses First Patient in Part 3 of Global Phase I/III Pivotal Study of rVIII-SingleChain (Recombinant Single-Chain Factor VIII) for Treatment of Hemophilia A
PR Newswire - Tue Jun 04, 8:00AM CDT
CSL Behring has dosed the first patient in Part 3 of its AFFINITY clinical trial program, which is now in phase III. AFFINITY is an open-label, non-randomized, multi-center study evaluating the efficacy, safety and pharmacokinetics of its novel investigational recombinant coagulation single-chain factor VIII (rVIII-SingleChain) for the treatment of hemophilia A. The patient was dosed in Vienna, Austria and had a successful major surgery.

CSL Behring Receives FDA Approval of Kcentra(TM) for Urgent Warfarin Reversal in Patients with Acute Major Bleeding
PR Newswire - Tue Apr 30, 9:13AM CDT
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) approved Kcentra(TM) (Prothrombin Complex Concentrate [Human]), the first non-activated 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (e.g., warfarin) therapy in adult patients with acute major bleeding. The pivotal clinical trial showed that Kcentra met all efficacy and safety endpoints, including the endpoints of hemostatic efficacy and International Normalized Ratio (INR) reduction compared with plasma, the most widely used agent for warfarin reversal in the United States.

CSL Behring Donates Medicine Used in Treating Bleeding Disorders to World Federation of Hemophilia
PR Newswire Europe - Wed Apr 03, 7:01AM CDT
-- CSL Behring initiates first "installment" of renewed 3-year commitment to WFH to donate coagulation factor to the WFH Global Alliance for Progress program

CSL Behring Receives FDA Approval to Expand the Indication for Corifact®
PR Newswire - Thu Feb 28, 8:00AM CST
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for Corifact®, Factor XIII Concentrate (Human), to include the peri-operative management of surgical bleeding in adult and pediatric patients with congenital factor XIII (FXIII) deficiency. In 2011, Corifact became the first and only FXIII concentrate approved in the U.S. for the routine prophylactic treatment of congenital factor XIII deficiency.

CSL Behring enrolls first patient in global pediatric Phase III pivotal study of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) to treat hemophilia B
PR Newswire Europe - Mon Jan 21, 8:00AM CST
-- CSL Behring achieves key milestone in PROLONG-9FP program
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 65

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
Fluence Energy Faces Heat: Class Action Lawsuit Unfolds

Updated Category News Views 73

Fluence Energy's Difficult Waters Investors in Fluence Energy (NASDAQ: FLNC) are having a moment of reckoning, no doubt. November 2nd saw a nearly 9% drop in FLNC stock, further fueled by the sudden departures of the CEO and CFO just days earlier. This marks a bitter chapter for Fluence as its stock continues to bleed, leaving many wondering what seismic shifts are yet to...

Continue Reading
Visit W&H at the Greater New York Dental Meeting

Updated Category News Views 89

Why This Event Matters for Dental Professionals Stroll through any convention center halls and you can see the future unfolding right in front of you. The upcoming Greater New York Dental Meeting is no different, especially with W&H Group setting up shop. For any dental professionals out there, this is your chance to get your hands on some real-deal tech that might just...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 113

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Tackling the Industrialized Beast of Insurance Fraud

Updated Category News Views 62

Stepping Up the Fraud Fight This year's emerging fraud trends are taking the term 'organized crime' to new heights, and it's painting a bullseye on the insurance industry. The National Insurance Crime Bureau (NICB) just laid out how fraud isn't just a series of isolated scams anymore—it's an industrial-scale racket. As they spotlight during International Fraud Awareness...

Continue Reading
Ontario Airport Braces for Holiday Travel Surge

Updated Category News Views 92

Gearing Up for a Thanksgiving Travel Boom Think Thanksgiving brings only turkey to the table? Down in Ontario, California, it's all about jet fuel and passenger counts. The Ontario International Airport (ONT) is where the skies are buzzing, forecasting over 227,000 passengers trying to soak up the holiday vibes by air. Compare that to the numbers when the local folks...

Continue Reading
DEFSEC Completes 9-to-1 Share Consolidation

Updated Category News Views 101

DEFSEC Technologies Tightens the Belt So, DEFSEC Technologies just pulled off something that'll kick up dust among investors. A 9-to-1 share consolidation—now that's no small fry. For those riding the NASDAQ or the TSX Venture with a tight grip on their DEFSEC shares, it's strictly business today. Post-consolidation, DEFSEC's common shares are set to trade under the...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
MISUMI Americas Expands, Ventures into New Horizons

Updated Category News Views 119

Marking New Territory in Monterrey MISUMI Americas is planting a new flag down in Monterrey, Mexico, with a sprawling 45,000-square-foot facility. This isn't just another expansion; it's a strategic move that's bound to shake things up in the manufacturing sector south of the border. When you've got a player like MISUMI widening their footprint, it catches the eye. Why?...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 163

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading

Top 5 Most Recently Viewed Articles

Koin CU and North Star CCU Utilize Mahalo for Digital Banking

Updated Category News Views 151

Revolutionizing Member Experience with Mahalo’s Platform Koin Credit Union and North Star Community Credit Union are excited to announce their partnership with Mahalo Banking, leveraging the innovative Thoughtful Banking platform to enhance the digital banking experience for their members. This collaboration signifies a commitment by both credit unions to prioritize...

Continue Reading
Exploring the Short Interest Trends of Bloom Energy Corp

Updated Category News Views 409

Bloom Energy Corp: Understanding Recent Short Interest Trends Bloom Energy Corp (NYSE: BE) has recently seen its short interest as a percentage of float decrease by 3.47%. According to the latest data, about 39.43 million shares are sold short, equating to approximately 23.93% of the available shares for trading. This situation indicates that traders would require an...

Continue Reading
Hurricane Season 2025: Essential Travel Insurance Insights

Updated Category News Views 315

Hurricane Season 2025: What Travelers Need to Know As hurricane season approaches in 2025, there are increasing concerns about its potential severity. Experts anticipate this could be one of the most active seasons we have seen in years, with predictions suggesting an alarming number of storms. With the aviation sector facing ongoing challenges and emergency training...

Continue Reading
Allendale Social: Nominated for Best Dining Honors

Updated Category News Views 310

Allendale Social Recognized for Culinary Excellence Allendale Social has received nominations for two esteemed categories from 201 Magazine: Best Fine Dining and Best New Restaurant. This recognition highlights the restaurant's commitment to quality and the exceptional dining experience it has cultivated in a relaxed yet upscale environment. The voting process is crucial,...

Continue Reading
Insmed Induces Growth with New Employee Stock Grants

Updated Category News Views 167

Insmed's Strategic Inducement Grants Enhance Workforce Insmed Incorporated (Nasdaq: INSM), a leading global biopharmaceutical company, has recently made headlines by announcing a significant inducement grant aimed at bolstering its workforce. This initiative highlights Insmed's commitment to attracting top talent to support its mission of developing transformative...

Continue Reading